Health in Chile

1,033 indicators covering health for Chile.

IndicatorLatest Year10-yr change Rank
Domestic general government health expenditure per capita 853.79 current US$ 2024 up 57.1% 54th
Share of out of pocket expenditure on healthcare 39.15 2024 up 14.2% 60th
Tuberculosis treatment success rate in new and relapsed cases 69 2023 up 46.8% 163rd
Share of public expenditure on healthcare by country 48.52 2024 up 1.6% 114th
Private health expenditure per person 1,859 2024 up 101.2% 13th
Public healthcare spending share gdp 5.11 2024 up 36.5% 50th
Health spending per person by source 1,752 2024 up 107.6% 55th
Poliomyelitis - number of reported cases 0 2018 β€” 8th
Number of new hiv infections per year 3,971 2024 up 19.4% 41st
Rubella vaccination coverage 93 2024 down 4.1% 76th
Mortality rate among children ages 10 to 14 years 0.7205 2020 down 28.1% 151st
Cost healthy diet 5.22 2024 up 54.4% 31st
Terrorism deaths by region 1 2021 β€” 49th
Medical doctors 68,987 2024 up 91.6% 37th
Adults (ages 15-49) newly infected with HIV 3,800 2024 up 18.8% 32nd
Mean systolic blood pressure 119.7 2015 down 1.2% 149th
UHC Service Coverage sub-index on infectious diseases 100 2023 up 3.1% 1st
UHC Service Coverage sub-index on service capacity and access 94 2023 up 19.0% 26th
UHC Service Coverage sub-index on reproductive, maternal, newborn and 87 2023 up 3.6% 22nd
UHC Service Coverage Index 84 2023 up 10.5% 23rd
UHC Service Coverage sub-index on noncommunicable diseases 61 2023 up 17.3% 116th
Stillbirth rate 2.75 2023 down 16.7% 171st
Number of stillbirths 486 2023 down 39.1% 112th
Hepb3 number unvaccinated 7,351 2023 down 69.5% 105th
Rotavirus vaccines completed dose (RotaC) immunization coverage among 0.0% 2025 β€” 138th
Young people (ages 15-24) newly infected with HIV 940 2024 unchanged 41st
Tb related deaths hiv 75 2023 up 141.9% 79th
Smoking bans in public places 8 2022 up 166.7% 1st
Current health expenditure (CHE) as percentage of gross domestic produ 10.2% 2023 up 36.1% 27th
External health expenditure (EXT) as percentage of current health expe 0.0% 2023 down 100.0% 148th
Domestic general government health expenditure (GGHE-D) as percentage 51.6% 2023 up 8.3% 107th
Out-of-pocket expenditure as percentage of current health expenditure 34.6% 2023 up 2.8% 69th
Domestic general government health expenditure (GGHE-D) as percentage 5.3% 2023 up 47.4% 50th
Domestic general government health expenditure (GGHE-D) as percentage 19.2% 2023 up 24.4% 15th
Domestic private health expenditure (PVT-D) as percentage of current h 48.4% 2023 down 7.6% 57th
Current health expenditure (CHE) per capita in US$ 1,737 2023 up 48.2% 45th
Domestic private health expenditure (PVT-D) per capita in US$ 840.37 2023 up 37.0% 30th
Domestic general government health expenditure (GGHE-D) per capita in 896.15 2023 up 60.5% 55th
Total healthcare expenditure gdp 10.17 2023 up 36.1% 27th
Health expenditure government expenditure 19.17 2023 up 24.4% 15th
Mumps - number of reported cases 3,410 2025 up 153.3% 14th
Incidence of tuberculosis (per 100 000 population) 1.7 2023 up 73.5% 91st
Hib vaccine 95 2024 unchanged 57th
Congenital Rubella Syndrome - number of reported cases 0 2025 β€” 16th
External health expenditure (EXT) per capita in US$ 0 2023 down 100.0% 151st
Dentists 32,969 2023 up 129.1% 19th
Nursing and midwifery personnel 93,214 2024 up 104.6% 50th
Nursing personnel 93,214 2024 up 168.8% 46th
Raised blood pressure (SBP>=140 OR DBP>=90) 23.89 2019 down 21.1% 154th
Raised blood pressure (SBP>=140 OR DBP>=90) 25.35 2019 down 17.1% 141st
Hypertension: diagnosis coverage among adults aged 30-79 with hyperten 71.2% 2019 up 4.7% 14th
Hypertension among adults aged 30-79 years, prevalence, age-standardiz 36.1 2019 down 8.8% 110th
Hypertension effective treatment coverage (controlled hypertension )am 33.7% 2019 up 44.0% 17th
Hypertension: effective treatment coverage (controlled hypertension) a 34.0% 2019 up 44.7% 21st
Hypertension treatment coverage among adults aged 30-79 with hypertens 60.0% 2019 up 13.9% 24th
Hypertension treatment coverage among adults aged 30-79 with hypertens 58.5% 2019 up 11.2% 24th
Hypertension: diagnosis coverage among adults aged 30-79 with hyperten 72.3% 2019 up 6.2% 19th
Hypertension among adults aged 30-79 years, prevalence, crude 38.4 2019 down 3.8% 77th
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati 94.0% 2025 up 4.4% 46th
Adolescent birth rate 0.0642 2023 down 95.7% 113th